NEW YORK (GenomeWeb News) — The Genome Institute of Singapore has purchased two of Sequenom’s MassArray systems and will use them with the company’s iPLEX Gold genotyping assay, Sequenom said today.
 
The institute also will use Sequenom’s EpiTYPER epigenetic assay, used to study DNA methylation for cancer research.
 
GIS senior investigator Edison Liu said the institute will use the tools in its studies of population genetics, fine mapping analysis, and breast cancer. 
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.